Mu-Peng Li
Impact in
-
- Antiplatelet Therapy and Cardiovascular Diseases
Papers in
-
- Antiplatelet Therapy and Cardiovascular Diseases 12
- Heart Failure Treatment and Management 3
-
- Platelet Disorders and Treatments 5
- Co-authors
- Xiaoping Chen (18 shared papers)Jie Tang (11 shared papers)Yanjiao Zhang (9 shared papers)Wenjing Zeng (3 shared papers)Linyu Yu (1 shared paper)Jie Tang (1 shared paper)Congmin Zhang (1 shared paper)Xiao‐Ping Chen (1 shared paper)
- Journals
- International Journal of Environmental Research and Public Health (4 papers)Gene (2 papers)Frontiers in Pharmacology (2 papers)Current Vascular Pharmacology (1 paper)International Journal of Hematology (1 paper)
- Partner nations
- ChinaUnited KingdomUnited States
In The Last Decade
Mu-Peng Li
25 papers receiving 335 citations
Peers
Comparison fields: 5 of 74
- Internal Medicine 18
- Cardiology and Cardiovascular Medicine 115
- Hematology 29
- Pharmacology 22
- Oncology 61
Countries citing papers authored by Mu-Peng Li
This map shows the geographic impact of Mu-Peng Li's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Mu-Peng Li with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Mu-Peng Li more than expected).
Fields of papers citing papers by Mu-Peng Li
This network shows the impact of papers produced by Mu-Peng Li. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Mu-Peng Li. The network helps show where Mu-Peng Li may publish in the future.
Co-authors
The 25 scholars most cited alongside Mu-Peng Li, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 29 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2017 | 86 | |
| 2 | 2017 | 44 | |
| 3 | 2016 | 28 | |
| 4 | 2016 | 21 | |
| 5 | 2017 | 20 | |
| 6 | 2016 | 15 | |
| 7 | 2014 | 14 | |
| 8 | 2017 | 13 | |
| 9 | 2018 | 12 | |
| 10 | 2015 | 12 | |
| 11 | 2018 | 10 | |
| 12 | 2014 | 8 | |
| 13 | 2017 | 8 | |
| 14 | 2022 | 7 | |
| 15 | 2017 | 7 | |
| 16 | 2020 | 7 | |
| 17 | 2017 | 7 | |
| 18 | 2021 | 6 | |
| 19 | 2017 | 6 | |
| 20 | 2013 | 5 |
About Mu-Peng Li
Mu-Peng Li is a scholar working on Cardiology and Cardiovascular Medicine, Hematology, Molecular Biology, Endocrinology, Diabetes and Metabolism and Cancer Research, having authored 29 papers that have together received 344 indexed citations. Recurring topics across this work include Antiplatelet Therapy and Cardiovascular Diseases (12 papers), Platelet Disorders and Treatments (5 papers), Diabetes Treatment and Management (4 papers), Heart Failure Treatment and Management (3 papers), Inflammatory mediators and NSAID effects (2 papers), Synthesis of β-Lactam Compounds (2 papers), Advanced Fiber Laser Technologies (2 papers) and RNA modifications and cancer (2 papers). The work is most often cited by research in Internal Medicine (18 citations), Cardiology and Cardiovascular Medicine (115 citations), Hematology (29 citations), Pharmacology (22 citations) and Oncology (61 citations). Mu-Peng Li has collaborated with scholars based in China, United Kingdom and United States. Frequent co-authors include Xiaoping Chen, Jie Tang, Yanjiao Zhang, Wenjing Zeng, Linyu Yu, Jie Tang, Congmin Zhang, Xiao‐Ping Chen, Xiaolei Hu and Yonglong Yang. Their work appears in journals such as International Journal of Environmental Research and Public Health, Gene, Frontiers in Pharmacology, Current Vascular Pharmacology and International Journal of Hematology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.